These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The emerging role of cytochrome P450 3A in psychopharmacology. Ketter TA; Flockhart DA; Post RM; Denicoff K; Pazzaglia PJ; Marangell LB; George MS; Callahan AM J Clin Psychopharmacol; 1995 Dec; 15(6):387-98. PubMed ID: 8748427 [TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450-mediated drug interactions. Flockhart DA; Oesterheld JR Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):43-76. PubMed ID: 10674190 [TBL] [Abstract][Full Text] [Related]
5. Avoiding psychotropic drug interactions in the cardiovascular patient. DeVane CL; Markowitz JS Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159 [TBL] [Abstract][Full Text] [Related]
6. Six patterns of drug-drug interactions. Armstrong SC; Cozza KL; Sandson NB Psychosomatics; 2003; 44(3):255-8. PubMed ID: 12724509 [TBL] [Abstract][Full Text] [Related]
8. Cytochrome P-450 monooxygenases and interactions of psychotropic drugs. Shen WW; Lin KM Int J Psychiatry Med; 1991; 21(1):47-56. PubMed ID: 2066257 [TBL] [Abstract][Full Text] [Related]
9. [Significance of hepatic cytochrome P450 enzymes for psychopharmacology]. Normann C; Hesslinger B; Bauer J; Berger M; Walden J Nervenarzt; 1998 Nov; 69(11):944-55. PubMed ID: 9859115 [TBL] [Abstract][Full Text] [Related]
10. Psychotropic drug metabolism in the cancer patient: clinical aspects of management of potential drug interactions. Kalash GR Psychooncology; 1998; 7(4):307-20. PubMed ID: 9741070 [TBL] [Abstract][Full Text] [Related]
11. [Interactions between psychopharmaceuticals and other drugs]. Markus W MMW Fortschr Med; 2006 Nov; 148(46):31-5. PubMed ID: 17615785 [TBL] [Abstract][Full Text] [Related]
13. Ethnopsychopharmacology. Chen CH; Chen CY; Lin KM Int Rev Psychiatry; 2008 Oct; 20(5):452-9. PubMed ID: 19012131 [No Abstract] [Full Text] [Related]
14. Drug-associated disease: cytochrome P450 interactions. Mann HJ Crit Care Clin; 2006 Apr; 22(2):329-45, vii. PubMed ID: 16678003 [TBL] [Abstract][Full Text] [Related]
15. The metabolism of psychoactive drugs: a review of enzymatic biotransformation and inhibition. Shen WW Biol Psychiatry; 1997 Apr; 41(7):814-26. PubMed ID: 9084901 [No Abstract] [Full Text] [Related]
16. Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Catterson ML; Preskorn SH; Martin RL Psychiatr Clin North Am; 1997 Mar; 20(1):205-18. PubMed ID: 9139291 [TBL] [Abstract][Full Text] [Related]
17. Cytochromes and psychotropic drug interactions. Taylor D; Lader M Br J Psychiatry; 1996 May; 168(5):529-32. PubMed ID: 8733789 [No Abstract] [Full Text] [Related]
18. Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology. Carson SW; Ousmanou AD; Hoyler SL Psychopharmacol Bull; 2002; 36(1):67-81. PubMed ID: 12397848 [TBL] [Abstract][Full Text] [Related]
19. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs]. Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacologic interactions of antibiotics and psychotropic drugs]. Joos AA Psychiatr Prax; 1998 Mar; 25(2):57-60. PubMed ID: 9577846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]